The recent withdrawal of rofecoxib (Vioxx) from the market has intensified controversy about the safety of cyclooxygenase (COX)-2 inhibitors. Results from several recently published studies address ...
Cyclooxygenase-2 (COX-2) inhibitors have long been employed to modulate inflammatory responses in a range of conditions, from arthritis to malignancies. In recent years, the convergence of ...
Ferroptosis plays an essential role in chronic liver diseases, and cyclooxygenase-2 (COX-2) affects liver fibrosis through multiple mechanisms. However, research on COX-2 regulation of ferroptosis in ...
Augusta University has patented NSAID derivatives acting as prostaglandin G/H synthase 1 (PTGS1; COX-1) and/or COX-2 inhibitors potentially useful for the treatment of inflammation and pain.
Scientists say combining a low-dose of THC with a common anti-inflammatory drug improved cognition and reduced Alzheimer’s-related brain changes in mice.
Paradigm Biopharmaceuticals (ASX: PAR) has entered into a binding term sheet with AVet Health to co-develop and license a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results